Gene, environment, microbiome and mucosal immune tolerance in rheumatoid arthritis

Rheumatology (United Kingdom)

Volumn 55, Issue 3, 2016, Pages 391-402

  Catrina, Anca I ^a   Deane, Kevin D ^b   Scher, Jose U ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Break in tolerance; Environmental risk factors; Genetic susceptibility; Microbiome; Rheumatoid arthritis

Indexed keywords

AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; HLA DQ8 ANTIGEN; HLA DR ANTIGEN; HLA DR4 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; TOBACCO SMOKE;

ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNITY; CROSS REACTION; ENVIRONMENTAL FACTOR; EPITHELIUM CELL; GENETIC ASSOCIATION; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; INNATE IMMUNITY; INTESTINE FLORA; LOWER RESPIRATORY TRACT; MICROBIAL COLONIZATION; MICROBIOME; MOUTH FLORA; MUCOSA INFLAMMATION; MUCOSAL IMMUNITY; NEWBORN PERIOD; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT MUCOSA; RHEUMATOID ARTHRITIS; SMOKING;

EID: 84965060881     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu469     Document Type: Article

References (125)

1. Aho K, Palosuo T, Heliovaara M et al. Antifilaggrin antibodies within ''normal'' range predict rheumatoid arthritis in a linear fashion. J Rheumatol 2000;27:2743-6.
2. Aho K, Heliovaara M, Knekt P et al. Serum immunoglobulins and the risk of rheumatoid arthritis. Ann Rheum Dis 1997;56:351-6.
3. Aho K, Palosuo T, Heliovaara M. Predictive significance of rheumatoid factor. J Rheumatol 1995;22:2186-7.
4. del Puente A, Knowler WC, Pettitt DJ, Bennett PH. The incidence of rheumatoid arthritis is predicted by rheumatoid factor titer in a longitudinal population study. Arthritis Rheum 1988;31:1239-44.
5. Rantapaa-Dahlqvist S, de Jong BA, Berglin E et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003;48:2741-9.
6. Nielen MM, van Schaardenburg D, Reesink HW et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004;50:380-6.
7. Majka DS, Deane KD, Parrish LA et al. Duration of preclinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis. Ann Rheum Dis 2008;67:801-7.
8. Demoruelle MK, Weisman MH, Simonian PL et al. Brief report: airways abnormalities and rheumatoid arthritisrelated autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity? Arthritis Rheum 2012;64:1756-61.
9. van de Sande MG, de Hair MJ, van der Leij C et al. Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase. Ann Rheum Dis 2011;70:772-7.
10. Bos WH, Wolbink GJ, Boers M et al. Arthritis development in patients with arthralgia is strongly associated with anticitrullinated protein antibody status: a prospective cohort study. Ann Rheum Dis 2010;69:490-4.
11. van de Stadt LA, Bos WH, Meursinge Reynders M et al. The value of ultrasonography in predicting arthritis in auto- antibody positive arthralgia patients: a prospective cohort study. Arthritis Res Ther 2010;12:R98.
12. El-Gabalawy HS, Robinson DB, Smolik I et al. Familial clustering of the serum cytokine profile in the relatives of rheumatoid arthritis patients. Arthritis Rheum 2012;64:1720-9.
13. El-Gabalawy HS, Robinson DB, Hart D et al. Immunogenetic risks of anti-cyclical citrullinated peptide antibodies in a North American Native population with rheumatoid arthritis and their first-degree relatives. J Rheumatol 2009;36:1130-5.
14. Battersby AJ, Gibbons DL. The gut mucosal immune system in the neonatal period. Pediatr Allergy Immunol 2013;24:414-21.
15. Berin MC, Sampson HA. Mucosal immunology of food allergy. Curr Biol 2013;23:R389-400.
16. Gill N, Wlodarska M, Finlay BB. The future of mucosal immunology: studying an integrated system-wide organ. Nat Immunol 2010;11:558-60.
17. Kato A, Hulse KE, Tan BK, Schleimer RP. B-lymphocyte lineage cells and the respiratory system. J Allergy Clin Immunol 2013;131:933-57, quiz 58.
18. Josefowicz SZ, Niec RE, Kim HY et al. Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature 2012;482:395-9.
19. Cerutti A, Chen K, Chorny A. Immunoglobulin responses at the mucosal interface. Ann Rev Immunol 2011;29:273-93.
20. Macpherson AJ, McCoy KD, Johansen FE, Brandtzaeg P. The immune geography of IgA induction and function. Mucosal Immunol 2008;1:11-22.
21. Chang SY, Ko HJ, Kweon MN. Mucosal dendritic cells shape mucosal immunity. Exp Mol Med 2014;46:e84.
22. Sheridan BS, Lefrancois L. Regional and mucosal memory T cells. Nat Immunol 2011;12:485-91.
23. Kozlowski PA, Neutra MR. The role of mucosal immunity in prevention of HIV transmission. Curr Mol Med 2003;3:217-28.
24. Chang F, Mahadeva U, Deere H. Pathological and clinical significance of increased intraepithelial lymphocytes (IELs) in small bowel mucosa. APMIS 2005;113:385-99.
25. Colonna M. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity 2009;31:15-23.
26. Ruddle NH, Akirav EM. Secondary lymphoid organs:responding to genetic and environmental cues in ontogeny and the immune response. J Immunol 2009;183:2205-12.
27. Fagarasan S, Honjo T. Intestinal IgA synthesis: regulation of front-line body defences. Nat Rev Immunol 2003;3:63-72.
28. Carragher DM, Rangel-Moreno J, Randall TD. Ectopic lymphoid tissues and local immunity. Sem Immunol 2008;20:26-42.
29. Randall TD, Carragher DM, Rangel-Moreno J. Development of secondary lymphoid organs. Annu Rev Immunol 2008;26:627-50.
30. Moyron-Quiroz JE, Rangel-Moreno J, Kusser K et al. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat Med 2004;10:927-34.
31. Kiyono H, Fukuyama S. NALT- versus Peyer's-patchmediated mucosal immunity. Nat Rev Immunol 2004;4:699-710.
32. Neutra MR, Kozlowski PA. Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 2006;6:148-58.
33. Lederberg J. Infectious history. Science 2000;288:287-93.
34. Qin J, Li R, Raes J et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010;464:59-65.
35. Human Microbiome Project C. Structure, function and diversity of the healthy human microbiome. Nature 2012;486:207-14.
36. Littman DR, Pamer EG. Role of the commensal microbiota in normal and pathogenic host immune responses. Cell Host Microbe 2011;10:311-23.
37. Gevers D, Kugathasan S, Denson LA et al. The treatmentnaive microbiome in new-onset Crohn's disease. Cell Host Microbe 2014;15:382-92.
38. Alekseyenko AV, Perez-Perez GI, De Souza A et al. Community differentiation of the cutaneous microbiota in psoriasis. Microbiome 2013;1:31.
39. Scher JU, Abramson SB. The microbiome and rheumatoid arthritis. Nat Rev Rheumatol 2011;7:569-78.
40. Yatsunenko T, Rey FE, Manary MJ et al. Human gut microbiome viewed across age and geography. Nature 2012;486:222-7.
41. Spor A, Koren O, Ley R. Unravelling the effects of the environment and host genotype on the gut microbiome. Nat Rev Microbiol 2011;9:279-90.
42. Rogier EW, Frantz AL, Bruno ME et al. Secretory antibodies in breast milk promote long-term intestinal homeostasis by regulating the gut microbiota and host gene expression. Proc Natl Acad Sci USA 2014;111:3074-9.
43. Peterson DA, McNulty NP, Guruge JL, Gordon JI. IgA response to symbiotic bacteria as a mediator of gut homeostasis. Cell Host Microbe 2007;2:328-39.
44. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004;118:229-41.
45. Cerf-Bensussan N, Gaboriau-Routhiau V. The immune system and the gut microbiota: friends or foes? Nat Rev Immunol 2010;10:735-44.
46. Kuhn KA, Stappenbeck TS. Peripheral education of the immune system by the colonic microbiota. Sem Immunol 2013;25:364-9.
47. Ivanov II, Atarashi K, Manel N et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009;139:485-98.
48. Wu HJ, Ivanov II, Darce J et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 2010;32:815-27.
49. Yang Y, Torchinsky MB, Gobert M et al. Focused specificity of intestinal TH17 cells towards commensal bacterial antigens. Nature 2014;510:152-6.
50. Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci USA 2010;107:12204-9.
51. Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008;453:620-5.
52. Ochoa-Reparaz J, Mielcarz DW, Ditrio LE et al. Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression. J Immunol 2010;185:4101-8.
53. Hooper LV, Macpherson AJ. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 2010;10:159-69.
54. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009;9:313-23.
55. Frank DN, St Amand AL, Feldman RA et al. Molecularphylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 2007;104:13780-5.
56. Manichanh C, Rigottier-Gois L, Bonnaud E et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006;55:205-11.
57. Wen L, Ley RE, Volchkov PY et al. Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 2008;455:1109-13.
58. Lee YK, Menezes JS, Umesaki Y, Mazmanian SK. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 2011;108(Suppl 1):4615-22.
59. Abdollahi-Roodsaz S, Joosten LA, Koenders MI et al. Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J Clin Invest 2008;118:205-16.
60. Scher JU, Sczesnak A, Longman RS et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. eLife 2013;2:e01202.
61. Barra L, Scinocca M, Saunders S et al. Anti-citrullinated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients. Arthritis Rheum 2013;65:1439-47.
62. Newkirk MM, Goldbach-Mansky R, Senior BW et al. Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis. Rheumatology 2005;44:1433-41.
63. Silman AJ, Pearson JE. Epidemiology and genetics of rheumatoid arthritis. Arthritis Res 2002;4(Suppl 3):S265-72.
64. Rashid T, Tiwana H, Wilson C, Ebringer A. Rheumatoid arthritis as an autoimmune disease caused by Proteus urinary tract infections: a proposal for a therapeutic protocol. Isr Med Assoc J 2001;3:675-80.
65. Mikuls TR, Thiele GM, Deane KD et al. Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk for future rheumatoid arthritis. Arthritis Rheum 2012;64:3522-30.
66. Cunningham MW. Streptococcus and rheumatic fever. Curr Opin Rheumatol 2012;24:408-16.
67. Makrygiannakis D, Af Klint E, Lundberg IE et al. Citrullination is an inflammation-dependent process. Ann Rheum Dis 2006;65:1219-22.
68. Shi J, van Veelen PA, Mahler M et al. Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies. Autoimmun Rev 2014;13:225-30.
69. Farquharson D, Butcher JP, Culshaw S. Periodontitis, Porphyromonas, and the pathogenesis of rheumatoid arthritis. Mucosal Immunol 2012;5:112-20.
70. Willis VC, Demoruelle MK, Derber LA et al. Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at risk of future clinically apparent disease. Arthritis Rheum 2013;65:2545-54.
71. Joshua V, Reynisdottir G, Ytterberg J et al. Characterization of lung inflammation and identification of shared citrullinated targets in the lungs and joints of early RA. Arthritis Rheum 2013;65:S392.
72. Fischer A, Solomon JJ, du Bois RM et al. Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease. Respir Med 2012;106:1040-7.
73. Rangel-Moreno J, Hartson L, Navarro C et al. Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Invest 2006;116:3183-94.
74. Reynisdottir G, Karimi R, Joshua V et al. Structural changes and antibody enrichment in the lungs are early features of anti-citrullinated protein antibody-positive rheumatoid arthritis. Arthritis Rheumatol 2014;66:31-9.
75. Klareskog L, Gregersen PK, Huizinga TW. Prevention of autoimmune rheumatic disease: state of the art and future perspectives. Ann Rheum Dis 2010;69:2062-6.
76. Makrygiannakis D, Hermansson M, Ulfgren AK et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 2008;67:1488-92.
77. Padyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum 2004;50:3085-92.
78. Klareskog L, Stolt P, Lundberg K et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLADR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006;54:38-46.
79. Huizinga TW, Amos CI, van der Helm-van Mil AH et al. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum 2005;52:3433-8.
80. Pedersen M, Jacobsen S, Klarlund M et al. Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides. Arthritis Res Ther 2006;8:R133.
81. Karlson EW, Chang SC, Cui J et al. Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis. Ann Rheum Dis 2010;69:54-60.
82. Too CL, Muhamad NA, Padyukov L et al. Geneenvironment interaction between HLA-DRB1 shared epitope and occupational textile dust exposure in the risk of ACPA-positive rheumatoid arthritis in female patients:evidence from the Malaysian epidemiological investigation of rheumatoid arthritis case-control study. Arthritis Rheum 2013;65:S457-8.
83. Haj Hensvold A, Magnusson PK, Joshua V et al. Environmental and genetic factors in the development of anticitrullinated protein antibodies (ACPAs) and ACPA-positive rheumatoid arthritis: an epidemiological investigation in twins. Ann Rheum Dis 2013 Nov 25. doi:10.1136/annrheumdis-2013-203947 [Epub ahead of print].
84. Hill JA, Southwood S, Sette A et al. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol 2003;171:538-41.
85. Raychaudhuri S, Sandor C, Stahl EA et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet 2012;44:291-6.
86. Scally SW, Petersen J, Law SC et al. A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis. J Exp Med 2013;210:2569-82.
87. Bellatin MF, Han M, Fallena M et al. Production of autoantibodies against citrullinated antigens/peptides by human B cells. J Immunol 2012;188:3542-50.
88. Vassallo R, Luckey D, Behrens M et al. Cellular and humoral immunity in arthritis are profoundly influenced by interaction between cigarette smoke effects and host HLA-DR and DQ genes. Clin Immunol 2014;152:25-35.
89. Ebringer A. Rheumatoid Arthritis and Proteus. London, UK: Springer-Verlag, 2012.
90. Ramirez AS, Rosas A, Hernandez-Beriain JA et al. Relationship between rheumatoid arthritis and Mycoplasma pneumoniae: a case-control study. Rheumatology 2005;44:912-4.
91. Scher JU, Ubeda C, Equinda M et al. Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis Rheum 2012;64:3083-94.
92. Van de Merwe JP, Stegeman JH, Hazenberg MP. The resident faecal flora is determined by genetic characteristics of the host Implications for Crohn's disease? Antonie van Leeuwenhoek 1983;49:119-24.
93. Hoeksma A, Winkler KC. The normal flora of the nose in twins. Acta Leidensia 1963;32:123-33.
94. Aly R, Maibach HI, Shinefield HR, Mandel AD. Staphylococcus aureus carriage in twins. Am J Dis Child 1974;127:486-8.
95. Andersen PS, Pedersen JK, Fode P et al. Influence of host genetics and environment on nasal carriage of Staphylococcus aureus in Danish middle-aged and elderly twins. J Infect Dis 2012;206:1178-84.
96. Vaahtovuo J, Toivanen P, Eerola E. Bacterial composition of murine fecal microflora is indigenous and genetically guided. FEMS Microbiol Ecol 2003;44:131-6.
97. Gomez A, Luckey D, Yeoman CJ et al. Loss of sex and age driven differences in the gut microbiome characterize arthritis-susceptible 0401 mice but not arthritis-resistant 0402 mice. PLoS One 2012;7:e36095.
98. Koeth RA, Wang Z, Levison BS et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 2013;19:576-85.
99. de Pablo P, Chapple IL, Buckley CD, Dietrich T. Periodontitis in systemic rheumatic diseases. Nat Rev Rheumatol 2009;5:218-24.
100. Kinloch A, Lundberg K, Wait R et al. Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis. Arthritis Rheum 2008;58:2287-95.
101. Haag S, Uysal H, Backlund J, Tuncel J, Holmdahl R. Human a-enolase is immunogenic, but not arthritogenic, in HLA-DR4-transgenic mice: comment on the article by Kinloch et al. Arthritis Rheum 2012;64:1689-91.
102. Demoruelle MK, Weisman MH, Simonian PL et al. Brief report: airways abnormalities and rheumatoid arthritisrelated autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity? Arthritis Rheum 2012;64:1756-61.
103. Demoruelle MK, Norris JM, Holers VM, Harris JK, Deane KD. The lung microbiome differs in asymptomatic subjects at elevated risk of future rheumatoid arthritis compared with healthy control subjects. Ann Am Thorac Soc 2014;11(Suppl 1):S74.
104. Biedermann L, Zeitz J, Mwinyi J et al. Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans. PLoS One 2013;8:e59260.
105. Zambon JJ, Grossi SG, Machtei EE et al. Cigarette smoking increases the risk for subgingival infection with periodontal pathogens. J Periodontol 1996;67(10 Suppl):1050-4.
106. Haffajee AD, Socransky SS. Relationship of cigarette smoking to the subgingival microbiota. J Clin Periodontol 2001;28:377-88.
107. van Winkelhoff AJ, Bosch-Tijhof CJ, Winkel EG, van der Reijden WA. Smoking affects the subgingival microflora in periodontitis. J Periodontol 2001;72:666-71.
108. Shchipkova AY, Nagaraja HN, Kumar PS. Subgingival microbial profiles of smokers with periodontitis. J Dental Res 2010;89:1247-53.
109. Bagaitkar J, Demuth DR, Daep CA et al. Tobacco upregulates P. gingivalis fimbrial proteins which induce TLR2 hyposensitivity. PLoS One 2010;5:e9323.
110. Goldstein-Daruech N, Cope EK, Zhao KQ et al. Tobacco smoke mediated induction of sinonasal microbial biofilms. PLoS One 2011;6:e15700.
111. Garmendia J, Morey P, Bengoechea JA. Impact of cigarette smoke exposure on host-bacterial pathogen interactions. Eur Respir J 2012;39:467-77.
112. Aho K, Heliovaara M, Maatela J, Tuomi T, Palosuo T. Rheumatoid factors antedating clinical rheumatoid arthritis. J Rheumatol 1991;18:1282-4.
113. Kurki P, Aho K, Palosuo T, Heliovaara M. Immunopathology of rheumatoid arthritis. Antikeratin antibodies precede the clinical disease. Arthritis Rheum 1992;35:914-7.
114. Chibnik LB, Mandl LA, Costenbader KH, Schur PH, Karlson EW. Comparison of threshold cutpoints and continuous measures of anti-cyclic citrullinated peptide antibodies in predicting future rheumatoid arthritis. J Rheumatol 2009;36:706-11.
115. Shi J, van de Stadt LA, Levarht EW et al. Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis. Ann Rheum Dis 2014;73:780-3.
116. de Hair MJ, van de Sande MG, Ramwadhdoebe TH et al. Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis. Arthritis Rheumatol 2014;66:513-22.
117. Kuhn KA, Kulik L, Tomooka B et al. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 2006;116:961-73.
118. Trouw LA, Haisma EM, Levarht EW et al. Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways. Arthritis Rheum 2009;60:1923-31.
119. Sokolove J, Zhao X, Chandra PE, Robinson WH. Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and Fcg receptor. Arthritis Rheum 2011;63:53-62.
120. Harre U, Georgess D, Bang H et al. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin invest 2012;122:1791-802.
121. Kleyer A, Finzel S, Rech J et al. Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies. Ann Rheum Dis 2014;73:854-60.
122. Joshua V, Reynisdottir G, Ytterberg J et al. A1.1 Characterisation of lung inflammation and identification of shared citrullinated targets in the lungs and joints of early rheumatoid arthritis. Ann Rheum Dis 2014; 73(Suppl 1):A4-5.
123. Brink M, Hansson M, Mathsson L et al. Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis. Arthritis Rheum 2013;65:899-910.
124. Hughes-Austin JM, Deane KD, Derber LA et al. Multiple cytokines and chemokines are associated with rheumatoid arthritis-related autoimmunity in first-degree relatives without rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA). Ann Rheum Dis 2013;72:901-7.
125. Sokolove J, Bromberg R, Deane KD et al. Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS One 2012;7:e35296.